Posts Tagged ‘Dupilumab’

Dupilumab versus Placebo in Atopic Dermatitis

Posted by • December 15th, 2016

For patients with moderate-to-severe atopic dermatitis, topical therapies have limited efficacy, and systemic treatments are associated with substantial toxic effects. Thus, there is an unmet need for effective and safe long-term medications for these patients. Simpson et al. reported the results of two phase 3 trials of dupilumab monotherapy (SOLO 1 and SOLO 2) in… Read More…

Dupilumab as a Treatment for Atopic Dermatitis

Posted by • July 9th, 2014

For thousands of years, our knowledge of medications has largely been based on trial and error: we haphazardly used substances and learned from the effects. Within the last half a century, however, rational drug design slowly took to the forefront as scientific discoveries improved our understanding of the underlying pathogenesis of diseases. While there have… Read More…

Another Bench-to-Bedside Story in the Treatment of Asthma

Posted by • June 26th, 2013

In the early 20th century, the physician’s toolbox for asthma included adrenergic stimulants and belladonna alkaloids derived from the thorn-apple plant. Fifty years later, corticosteroids were added to the repertoire. (See the NEJM 200th anniversary review article on asthma.) But the next 50 years witnessed much more accelerated changes as basic science advances inspired the… Read More…